BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11756856)

  • 21. CNS prophylaxis of childhood leukemia: what are the long-term neurological, neuropsychological, and behavioral effects?
    Stehbens JA; Kaleita TA; Noll RB; MacLean WE; O'Brien RT; Waskerwitz MJ; Hammond GD
    Neuropsychol Rev; 1991 Jun; 2(2):147-77. PubMed ID: 1844707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotoxicity of intrathecal methotrexate: MR imaging findings.
    Sandoval C; Kutscher M; Jayabose S; Tenner M
    AJNR Am J Neuroradiol; 2003 Oct; 24(9):1887-90. PubMed ID: 14561622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings.
    Dicuonzo F; Salvati A; Palma M; Lefons V; Lasalandra G; De Leonardis F; Santoro N
    J Child Neurol; 2009 Aug; 24(8):1013-8. PubMed ID: 19307676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
    Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U
    Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute tumor lysis syndrome following intrathecal methotrexate.
    Benekli M; Güllü IH; Savaş MC; Kadayifçi A; Altundağ MK; Tekuzman G; Firat D
    Leuk Lymphoma; 1996 Jul; 22(3-4):361-3. PubMed ID: 8819088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?
    Khan RB; Shi W; Thaler HT; DeAngelis LM; Abrey LE
    J Neurooncol; 2002 Jun; 58(2):175-8. PubMed ID: 12164690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent hyponatremia after intrathecal methotrexate not related to antidiuretic hormone: is a natriuretic peptide activated?
    Diskin C; Dansby LM; Radcliff L; Carter TB; Graves E; Graves A
    Am J Med Sci; 2006 Jan; 331(1):37-9. PubMed ID: 16415663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials.
    Vainionpää L; Kovala T; Tolonen U; Lanning M
    Med Pediatr Oncol; 1997 Jan; 28(1):41-7. PubMed ID: 8950335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary central nervous system lymphoma presenting as Parinaud syndrome.
    Cheung T; Proulx A; Fraser JA
    Can J Ophthalmol; 2011 Oct; 46(5):445-6. PubMed ID: 21995994
    [No Abstract]   [Full Text] [Related]  

  • 30. Pendular Seesaw Nystagmus in a Patient With a Giant Pituitary Macroadenoma: Pathophysiology and the Role of the Accessory Optic System.
    Yat-Ming Woo P; Takemura S; Ming-Yan Cheong A; Chi-Ho Chu A; Chan Y; Wong HT; Chan KY
    J Neuroophthalmol; 2018 Mar; 38(1):65-69. PubMed ID: 29135813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual loss despite anticoagulation in radiation-induced optic neuropathy.
    Danesh-Meyer HV; Savino PJ; Sergott RC
    Clin Exp Ophthalmol; 2004 Jun; 32(3):333-5. PubMed ID: 15180850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate myelopathy after intrathecal chemotherapy: a case report.
    Murata KY; Maeba A; Yamanegi M; Nakanishi I; Ito H
    J Med Case Rep; 2015 Jun; 9():135. PubMed ID: 26055509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Necrotizing myelopathy after intrathecal methotrexate].
    Sanhes L; Delmer A; Zittoun R
    Presse Med; 1997 May 3-10; 26(15):719. PubMed ID: 9183374
    [No Abstract]   [Full Text] [Related]  

  • 34. Methotrexate-induced posterior reversible encephalopathy syndrome.
    Aradillas E; Arora R; Gasperino J
    J Clin Pharm Ther; 2011 Aug; 36(4):529-36. PubMed ID: 21210832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate induced seizures associated with acute reversible magnetic resonance imaging (MRI) changes in a patient with acute lymphoblastic leukemia.
    Rao RD; Swanson JW; Dejesus RS; Hunt CH; Tefferi A
    Leuk Lymphoma; 2002 Jun; 43(6):1333-6. PubMed ID: 12153004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascending myelopathy after intrathecal methotrexate.
    Chiu YH; Yang E; Chen YC
    Kaohsiung J Med Sci; 2021 Nov; 37(11):1018-1019. PubMed ID: 34292665
    [No Abstract]   [Full Text] [Related]  

  • 37. High-dose methotrexate monotherapy followed by radiation for CD30-positive, anaplastic lymphoma kinase-1-positive anaplastic large-cell lymphoma in the brain of a child.
    Furuya K; Takanashi S; Ogawa A; Takahashi Y; Nakagomi T
    J Neurosurg Pediatr; 2014 Sep; 14(3):311-5. PubMed ID: 25014324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases].
    Cartier R L; Parra V J; Puga B; Cardemil D
    Rev Med Chil; 2018 Jun; 146(6):802-807. PubMed ID: 30148913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy of primary cerebral lymphoma].
    Delwail V; Bataille B
    Neurochirurgie; 1997; 43(6):380-4. PubMed ID: 9706617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.